The Entanglement between Metabolic Associated Non- Alcoholic Fatty liver Disease and Chronic Kidney Disease Progression is more than just a Strong Correlation. A Narrative Review

Review Article

The Entanglement between Metabolic Associated Non- Alcoholic Fatty liver Disease and Chronic Kidney Disease Progression is more than just a Strong Correlation. A Narrative Review

  • Mohamed A Nasreldin 1*
  • Sayed Essam 1
  • Muaz Ahmed 1
  • Mahmoud Alnokeety 1
  • Tamer Elsalamony 1
  • Abdulsalam Noor 1
  • Ibraheem Saeed 1

*Corresponding Author: Mohamed A Nasreldin, University of Dammam, KFHU, KSA.

Citation: Mohamed A Nasreldin, Sayed Essam, Muaz Ahmed, Mahmoud Alnokeety, Tamer Elsalamony. et all (2022). The Entanglement between Metabolic Associated Non- Alcoholic Fatty liver Disease and Chronic Kidney Disease Progression is more than just a Strong Correlation. A Narrative Review. International Journal of Clinical Nephrology. 4(2); DOI:10.31579/2834-5142/036

Copyright: © 2022 Mohamed A Nasreldin. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Received: 08 August 2022 | Accepted: 22 August 2022 | Published: 30 August 2022

Keywords: NAFLD; NASH; MAFLD; CKD; fatty liver disease; microalbuminuria; hypertension; DM

Abstract

The aim of this narrative review is to shed light on the correlation between metabolic-associated fatty liver disease (MAFLD) and chronic kidney disease progression (CKD). There is robust evidence from the current and recent literature that MAFLD is strongly associated with CKD incidence and progression regardless of the other confounding factors such as DM, hypertension, dyslipidemia, age, and gender. we believe that MAFLD and CKD are two important health issues, both have a global and economic burden that will continue to rise over the coming years.  Primary and secondary care physicians, particularly nephrologists should be fully aware of the impact of MAFLD on CKD patients so they can participate actively in the management plan of these patients to reduce the comorbidities and economic costs associated with it.

Methodology:

The review identified and included the most recent few studies that described the problem of interest. Recommendations are given based on our perception, interpretation, and synthesis of data from the reviewed literature.

Results:

The existence of a strong correlation between MAFLD and CKD was persistent across all the reviewed studies and articles. This correlation was independent of other traditional risk factors such as hypertension, diabetes mellitus, hyperlipidemia, gender, and age.

Conclusion:

The global prevalence of MAFLD among the general population is high reaching 30% and almost 50% of CKD patients have MAFLD. There is a strong and independent association between MAFLD and CKD incidence and progression, thus patients diagnosed with CKD should be screened for MAFLD and managed accordingly to prevent and delay CKD progression. 

Introduction

Nonalcoholic fatty liver disease (NAFLD) is characterized by the presence of hepatic steatosis when no other causes for secondary hepatic fat accumulation are present. NAFLD can progress to cirrhosis. It is important to know that NAFLD is subclassified into nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). In NAFL, hepatic steatosis is present without evidence of significant inflammation, whereas in NASH, hepatic steatosis is associated with hepatic inflammation.

The worldwide prevalence of NAFLD is 35%, In a prospective study of 400 US military personnel and their families (mean age 55 years), the prevalence of NAFLD diagnosed by ultrasound was 46%. The diagnosis of MAFLD is based on the presence of hepatic steatosis (detected by serum biomarker scores, imaging techniques or liver biopsy) and at least one of the following metabolic criteria: (a) obesity, (b) T2DM, and (c) metabolic disorders, i.e., at least two additional factors amongst increased waist circumference, hypertension, hypertriglyceridemia, low serum HDL-cholesterol levels, impaired fasting glucose, insulin resistance or subclinical inflammation. It is essential to mention that several observational studies have recently revealed and reported that the definition of MAFLD, compared with NAFLD may significantly improve the stratification of patients at higher risk of developing hepatic and extra-hepatic complications, such as CKD progression, the topic of this narrative review. Chronic kidney disease (CKD) is associated with an increased risk of morbidity and mortality, as well as with a high economic cost [18]. The prevalence of CKD worldwide is approximately 10% and it is expected that CKD might become the fifth cause of death globally in 2040. Several retrospective and prospective observational studies and systematic reviews during the last fifteen years proved the existence of a strong correlation between NAFLD and CKD progression, however the new term of MAFLD is more helpful and meaningful in stratification of CKD patients at substantial risk of progression. Several epidemiological studies and meta-analyses have demonstrated that NAFLD (detected by blood biomarkers/scores, imaging techniques, International Classification of Diseases codes or liver biopsy) is associated with an increased risk of incident CKD, independent of established CKD risk factors, diabetes, hypertension, proteinuria, and other potential confounders (20-25). The correlation between the two diseases is complex and important at the same time because both diseases are current global health issues and will continue to be a global and economic burden in the future if no serious preventive measures are put in place. 

NAFLD and Risk of CKD progression:

The meta-analysis of 13 observational longitudinal studies involving nearly 1 200 000 middle-aged individuals (28.1% with NAFLD; n=3 43 248) from different countries revealed that the long-term risk of developing CKD stage ≥3 is increased ~1.45-fold in individuals with NAFLD (Mantovani, et al. 2020). This risk increases with the severity of liver fibrosis. The table [1] demonstrates the findings of a systematic analysis of 9 studies by (Mantovani, et al. 2017)

One can conclude from this systematic analysis that Patients with NAFLD are higher risk of incident CKD than those without NAFLD (random-effects hazard ratio [HR] 1.37, 95% CI 1.20–1.53; I 2 = 33.5%). These findings are consistent with the other studies that looked at the correlation between NAFLD and CKD in the current literature.

Correlation between MALD and CKD:

The table (2) below demonstrates the association between metabolic associated nonalcoholic liver disease (MALD) and chronic kidney disease (CKD), (Mantovani, et al.2022).

We believe that the notion of metabolic associated nonalcoholic fatty liver disease (MAFLA) is clearer and more comprehensive for nephrologist, general internists, family medicine physicians, endocrinologists, and primary care physicians, when they stratify patients at high risk of developing CKD or CKD progression, albeit there is no great statistical difference between MAFLD and NAFLD in terms of CKD risk. However, several studies in the previous systematic review had shown that the risk of CKD and CKD progression is higher in the MALD group compared to NAFLD group. Thus, a holistic approach to manage this category of patients is extremely important at the level of primary and secondary care. The figure below can help and guide the concerned physicians to detect MALD as early as possible.

Pathogenesis:

The pathogenesis of MAFLD and CKD is very complex, and it is still difficult to say that MAFLD can cause CKD, though there is robust evidence about the existence of a strong correlation between the two conditions regardless of the existence of other confounding factors such as diabetes mellitus, hypertension, and proteinuria. The illustration below demonstrates how the traditional risk factors are entangled between the two diseases.

Genetic role:

The PNPLA3 rs738409 polymorphism which is associated with a predisposition to NASH has recently been shown to associate with worse kidney function, (Guangrong Dai, et al. 2019). One can extrapolate from this genetic evidence, that any patient with MAFLD is at high risk of CKD and CKD progression.

Nephrologists and MAFLD, what can be done?

Nephrologists are amongst the first line physicians who can detect MAFLD because of high rate of patient's referral and consultations as well as high rate of requesting abdominal ultrasound. However, the lack of current strong evidenced guidelines and management policy make the concise management of such patients weak. To entice the attention of nephrologists and renal medicine clinicians to this health problem, one must speak of CKD progression risk based on the CKD stages and albuminuria (KDIGO guidelines) as illustrated in the table below. The risk of CKD progression and cardiovascular disease increase as the patients GFR decreases but it is not just the GFR that determines the risk of CKD progression but also the level of albuminuria, i.e., a patient with CKD stage 1 and proteinuria A3 will have the same risk of CKD progression as a patient with CKD stage 3b without microalbuminuria. One can imagine if MAFLD status is added to the table of CKD stages and albumin to creatinine ratio how the colors of CKD progression risk would change. This suggestion can help nephrologists to stratify patients at risk of CKD progression better than before and to manage patients with MAFLD and CKD properly rather than just advising them to reduce weight because weight loss at this stage is a treatment goal and should be achieved by all available means and monitored. Patients with advanced MAFLD with liver fibrosis should be referred to hepatologist as early as possible.   

Diagnosis of MAFLD:

The diagnosis of MAFLD can be performed based on the presence of:

  •  Hepatic steatosis (detected by serum biomarker scores, imaging techniques or liver biopsy) and at least one of the following metabolic criteria:
  • (a) overweight/obesity,
  • (b) T2DM,
  • (c) metabolic dysregulation.

Non-Medical Management:

  • Dietician consultation.
  • Regular exercise
  • Participation in weight reduction programs.

Medical Management:

Unfortunately, there is no specific cure for MAFLD but luckily these days there are many drugs and treatment options that can help reduce weight and proteinuria at the same time and reduce the risk of renal function decline as well as reducing the risk of cardiovascular disease. Medications such as metformin, SGLT2 inhibitors, G LIKE 1 receptor agonists etc. Some authors suggest Vitamin E (800 international units per day) (level of evidence is Grade 2C).

Surgical Management:

Bariatric surgery, patients with NASH or advanced fibrosis (but without decompensated cirrhosis) for bariatric surgery if they do not meet their weight loss goals after six months of lifestyle interventions.

The main goal of either medical or surgical management is to reduce weight because early weight reduction can reverse the disease and decrease the risk of liver fibrosis as well as risk of developing CKD or CKD progression. The figure below (William N, et al. 2016) shows how weight reduction is effective.

Laboratory monitoring:

  • AST AND ALT three and six months after patients with NAFLD implement lifestyle interventions for weight loss.
  • AST AND ALT three and six months after patients with NAFLD implement lifestyle interventions for weight loss.
  • For patients who achieve their weight loss goals and have normal serum aminotransferases, obtain a noninvasive assessment every four years.

When patients should be referred to hepatologist?

  • Aminotransferases (alanine aminotransferase and aspartate aminotransferase) that remain elevated despite loss of ≥5 percent of body weight (to evaluate for other etiologies of liver disease)
  • Aminotransferases (alanine aminotransferase and aspartate aminotransferase) that remain elevated despite loss of ≥5 percent of body weight (to evaluate for other etiologies of liver disease)
  • Steatohepatitis on liver biopsy
  • Steatohepatitis on liver biopsy

Recommendations:

  • The use of the new definition MAFLD, compared to NAFLD, offers numerous advantages in clinical, epidemiological, risk stratification of CKD and research terms in the future.
  • Patients diagnosed with NAFLD and at considerable risk of CKD should be managed by a multidisciplinary approach and motivated to change lifestyle and reduce weight.
  • Future prospective studies involving different ethnicities to further explore the association between MAFLD, and CKD progression should be encouraged
  • Based on the evidence from the current and recent literature about the strong correlation of MAFLD and CKD regardless of the existence of proteinuria, we suggest that MAFLD should be added to the KDIGO table of CKD stages and albumin to creatinine ratio to better stratify patients at risk of CKD and CVD. This can enable concerned physicians to put effective preventive measures in place.

Conclusion:

The entanglement between MAFLD and CKD incidence and progression seems to be more than just a simple correlation as evidenced in the current literature, however more randomized controlled studies should be encouraged in the future to explore the causal relationship between them. Meanwhile it is important to set forward early management and preventive measures in patients with CKD and MAFLD to avoid rapid decline of kidney function and CKD progression.

References

Clearly Auctoresonline and particularly Psychology and Mental Health Care Journal is dedicated to improving health care services for individuals and populations. The editorial boards' ability to efficiently recognize and share the global importance of health literacy with a variety of stakeholders. Auctoresonline publishing platform can be used to facilitate of optimal client-based services and should be added to health care professionals' repertoire of evidence-based health care resources.

img

Virginia E. Koenig

Journal of Clinical Cardiology and Cardiovascular Intervention The submission and review process was adequate. However I think that the publication total value should have been enlightened in early fases. Thank you for all.

img

Delcio G Silva Junior

Journal of Women Health Care and Issues By the present mail, I want to say thank to you and tour colleagues for facilitating my published article. Specially thank you for the peer review process, support from the editorial office. I appreciate positively the quality of your journal.

img

Ziemlé Clément Méda

Journal of Clinical Research and Reports I would be very delighted to submit my testimonial regarding the reviewer board and the editorial office. The reviewer board were accurate and helpful regarding any modifications for my manuscript. And the editorial office were very helpful and supportive in contacting and monitoring with any update and offering help. It was my pleasure to contribute with your promising Journal and I am looking forward for more collaboration.

img

Mina Sherif Soliman Georgy

We would like to thank the Journal of Thoracic Disease and Cardiothoracic Surgery because of the services they provided us for our articles. The peer-review process was done in a very excellent time manner, and the opinions of the reviewers helped us to improve our manuscript further. The editorial office had an outstanding correspondence with us and guided us in many ways. During a hard time of the pandemic that is affecting every one of us tremendously, the editorial office helped us make everything easier for publishing scientific work. Hope for a more scientific relationship with your Journal.

img

Layla Shojaie

The peer-review process which consisted high quality queries on the paper. I did answer six reviewers’ questions and comments before the paper was accepted. The support from the editorial office is excellent.

img

Sing-yung Wu

Journal of Neuroscience and Neurological Surgery. I had the experience of publishing a research article recently. The whole process was simple from submission to publication. The reviewers made specific and valuable recommendations and corrections that improved the quality of my publication. I strongly recommend this Journal.

img

Orlando Villarreal

Dr. Katarzyna Byczkowska My testimonial covering: "The peer review process is quick and effective. The support from the editorial office is very professional and friendly. Quality of the Clinical Cardiology and Cardiovascular Interventions is scientific and publishes ground-breaking research on cardiology that is useful for other professionals in the field.

img

Katarzyna Byczkowska

Thank you most sincerely, with regard to the support you have given in relation to the reviewing process and the processing of my article entitled "Large Cell Neuroendocrine Carcinoma of The Prostate Gland: A Review and Update" for publication in your esteemed Journal, Journal of Cancer Research and Cellular Therapeutics". The editorial team has been very supportive.

img

Anthony Kodzo-Grey Venyo

Testimony of Journal of Clinical Otorhinolaryngology: work with your Reviews has been a educational and constructive experience. The editorial office were very helpful and supportive. It was a pleasure to contribute to your Journal.

img

Pedro Marques Gomes

Dr. Bernard Terkimbi Utoo, I am happy to publish my scientific work in Journal of Women Health Care and Issues (JWHCI). The manuscript submission was seamless and peer review process was top notch. I was amazed that 4 reviewers worked on the manuscript which made it a highly technical, standard and excellent quality paper. I appreciate the format and consideration for the APC as well as the speed of publication. It is my pleasure to continue with this scientific relationship with the esteem JWHCI.

img

Bernard Terkimbi Utoo

This is an acknowledgment for peer reviewers, editorial board of Journal of Clinical Research and Reports. They show a lot of consideration for us as publishers for our research article “Evaluation of the different factors associated with side effects of COVID-19 vaccination on medical students, Mutah university, Al-Karak, Jordan”, in a very professional and easy way. This journal is one of outstanding medical journal.

img

Prof Sherif W Mansour

Dear Hao Jiang, to Journal of Nutrition and Food Processing We greatly appreciate the efficient, professional and rapid processing of our paper by your team. If there is anything else we should do, please do not hesitate to let us know. On behalf of my co-authors, we would like to express our great appreciation to editor and reviewers.

img

Hao Jiang

As an author who has recently published in the journal "Brain and Neurological Disorders". I am delighted to provide a testimonial on the peer review process, editorial office support, and the overall quality of the journal. The peer review process at Brain and Neurological Disorders is rigorous and meticulous, ensuring that only high-quality, evidence-based research is published. The reviewers are experts in their fields, and their comments and suggestions were constructive and helped improve the quality of my manuscript. The review process was timely and efficient, with clear communication from the editorial office at each stage. The support from the editorial office was exceptional throughout the entire process. The editorial staff was responsive, professional, and always willing to help. They provided valuable guidance on formatting, structure, and ethical considerations, making the submission process seamless. Moreover, they kept me informed about the status of my manuscript and provided timely updates, which made the process less stressful. The journal Brain and Neurological Disorders is of the highest quality, with a strong focus on publishing cutting-edge research in the field of neurology. The articles published in this journal are well-researched, rigorously peer-reviewed, and written by experts in the field. The journal maintains high standards, ensuring that readers are provided with the most up-to-date and reliable information on brain and neurological disorders. In conclusion, I had a wonderful experience publishing in Brain and Neurological Disorders. The peer review process was thorough, the editorial office provided exceptional support, and the journal's quality is second to none. I would highly recommend this journal to any researcher working in the field of neurology and brain disorders.

img

Dr Shiming Tang

Dear Agrippa Hilda, Journal of Neuroscience and Neurological Surgery, Editorial Coordinator, I trust this message finds you well. I want to extend my appreciation for considering my article for publication in your esteemed journal. I am pleased to provide a testimonial regarding the peer review process and the support received from your editorial office. The peer review process for my paper was carried out in a highly professional and thorough manner. The feedback and comments provided by the authors were constructive and very useful in improving the quality of the manuscript. This rigorous assessment process undoubtedly contributes to the high standards maintained by your journal.

img

Raed Mualem

International Journal of Clinical Case Reports and Reviews. I strongly recommend to consider submitting your work to this high-quality journal. The support and availability of the Editorial staff is outstanding and the review process was both efficient and rigorous.

img

Andreas Filippaios

Thank you very much for publishing my Research Article titled “Comparing Treatment Outcome Of Allergic Rhinitis Patients After Using Fluticasone Nasal Spray And Nasal Douching" in the Journal of Clinical Otorhinolaryngology. As Medical Professionals we are immensely benefited from study of various informative Articles and Papers published in this high quality Journal. I look forward to enriching my knowledge by regular study of the Journal and contribute my future work in the field of ENT through the Journal for use by the medical fraternity. The support from the Editorial office was excellent and very prompt. I also welcome the comments received from the readers of my Research Article.

img

Dr Suramya Dhamija

Dear Erica Kelsey, Editorial Coordinator of Cancer Research and Cellular Therapeutics Our team is very satisfied with the processing of our paper by your journal. That was fast, efficient, rigorous, but without unnecessary complications. We appreciated the very short time between the submission of the paper and its publication on line on your site.

img

Bruno Chauffert

I am very glad to say that the peer review process is very successful and fast and support from the Editorial Office. Therefore, I would like to continue our scientific relationship for a long time. And I especially thank you for your kindly attention towards my article. Have a good day!

img

Baheci Selen

"We recently published an article entitled “Influence of beta-Cyclodextrins upon the Degradation of Carbofuran Derivatives under Alkaline Conditions" in the Journal of “Pesticides and Biofertilizers” to show that the cyclodextrins protect the carbamates increasing their half-life time in the presence of basic conditions This will be very helpful to understand carbofuran behaviour in the analytical, agro-environmental and food areas. We greatly appreciated the interaction with the editor and the editorial team; we were particularly well accompanied during the course of the revision process, since all various steps towards publication were short and without delay".

img

Jesus Simal-Gandara

I would like to express my gratitude towards you process of article review and submission. I found this to be very fair and expedient. Your follow up has been excellent. I have many publications in national and international journal and your process has been one of the best so far. Keep up the great work.

img

Douglas Miyazaki

We are grateful for this opportunity to provide a glowing recommendation to the Journal of Psychiatry and Psychotherapy. We found that the editorial team were very supportive, helpful, kept us abreast of timelines and over all very professional in nature. The peer review process was rigorous, efficient and constructive that really enhanced our article submission. The experience with this journal remains one of our best ever and we look forward to providing future submissions in the near future.

img

Dr Griffith

I am very pleased to serve as EBM of the journal, I hope many years of my experience in stem cells can help the journal from one way or another. As we know, stem cells hold great potential for regenerative medicine, which are mostly used to promote the repair response of diseased, dysfunctional or injured tissue using stem cells or their derivatives. I think Stem Cell Research and Therapeutics International is a great platform to publish and share the understanding towards the biology and translational or clinical application of stem cells.

img

Dr Tong Ming Liu

I would like to give my testimony in the support I have got by the peer review process and to support the editorial office where they were of asset to support young author like me to be encouraged to publish their work in your respected journal and globalize and share knowledge across the globe. I really give my great gratitude to your journal and the peer review including the editorial office.

img

Husain Taha Radhi

I am delighted to publish our manuscript entitled "A Perspective on Cocaine Induced Stroke - Its Mechanisms and Management" in the Journal of Neuroscience and Neurological Surgery. The peer review process, support from the editorial office, and quality of the journal are excellent. The manuscripts published are of high quality and of excellent scientific value. I recommend this journal very much to colleagues.

img

S Munshi

Dr.Tania Muñoz, My experience as researcher and author of a review article in The Journal Clinical Cardiology and Interventions has been very enriching and stimulating. The editorial team is excellent, performs its work with absolute responsibility and delivery. They are proactive, dynamic and receptive to all proposals. Supporting at all times the vast universe of authors who choose them as an option for publication. The team of review specialists, members of the editorial board, are brilliant professionals, with remarkable performance in medical research and scientific methodology. Together they form a frontline team that consolidates the JCCI as a magnificent option for the publication and review of high-level medical articles and broad collective interest. I am honored to be able to share my review article and open to receive all your comments.

img

Tania Munoz

“The peer review process of JPMHC is quick and effective. Authors are benefited by good and professional reviewers with huge experience in the field of psychology and mental health. The support from the editorial office is very professional. People to contact to are friendly and happy to help and assist any query authors might have. Quality of the Journal is scientific and publishes ground-breaking research on mental health that is useful for other professionals in the field”.

img

George Varvatsoulias

Dear editorial department: On behalf of our team, I hereby certify the reliability and superiority of the International Journal of Clinical Case Reports and Reviews in the peer review process, editorial support, and journal quality. Firstly, the peer review process of the International Journal of Clinical Case Reports and Reviews is rigorous, fair, transparent, fast, and of high quality. The editorial department invites experts from relevant fields as anonymous reviewers to review all submitted manuscripts. These experts have rich academic backgrounds and experience, and can accurately evaluate the academic quality, originality, and suitability of manuscripts. The editorial department is committed to ensuring the rigor of the peer review process, while also making every effort to ensure a fast review cycle to meet the needs of authors and the academic community. Secondly, the editorial team of the International Journal of Clinical Case Reports and Reviews is composed of a group of senior scholars and professionals with rich experience and professional knowledge in related fields. The editorial department is committed to assisting authors in improving their manuscripts, ensuring their academic accuracy, clarity, and completeness. Editors actively collaborate with authors, providing useful suggestions and feedback to promote the improvement and development of the manuscript. We believe that the support of the editorial department is one of the key factors in ensuring the quality of the journal. Finally, the International Journal of Clinical Case Reports and Reviews is renowned for its high- quality articles and strict academic standards. The editorial department is committed to publishing innovative and academically valuable research results to promote the development and progress of related fields. The International Journal of Clinical Case Reports and Reviews is reasonably priced and ensures excellent service and quality ratio, allowing authors to obtain high-level academic publishing opportunities in an affordable manner. I hereby solemnly declare that the International Journal of Clinical Case Reports and Reviews has a high level of credibility and superiority in terms of peer review process, editorial support, reasonable fees, and journal quality. Sincerely, Rui Tao.

img

Rui Tao

Clinical Cardiology and Cardiovascular Interventions I testity the covering of the peer review process, support from the editorial office, and quality of the journal.

img

Khurram Arshad

Clinical Cardiology and Cardiovascular Interventions, we deeply appreciate the interest shown in our work and its publication. It has been a true pleasure to collaborate with you. The peer review process, as well as the support provided by the editorial office, have been exceptional, and the quality of the journal is very high, which was a determining factor in our decision to publish with you.

img

Gomez Barriga Maria Dolores

The peer reviewers process is quick and effective, the supports from editorial office is excellent, the quality of journal is high. I would like to collabroate with Internatioanl journal of Clinical Case Reports and Reviews journal clinically in the future time.

img

Lin Shaw Chin

Clinical Cardiology and Cardiovascular Interventions, I would like to express my sincerest gratitude for the trust placed in our team for the publication in your journal. It has been a true pleasure to collaborate with you on this project. I am pleased to inform you that both the peer review process and the attention from the editorial coordination have been excellent. Your team has worked with dedication and professionalism to ensure that your publication meets the highest standards of quality. We are confident that this collaboration will result in mutual success, and we are eager to see the fruits of this shared effort.

img

Maria Dolores Gomez Barriga

Dear Dr. Jessica Magne, Editorial Coordinator 0f Clinical Cardiology and Cardiovascular Interventions, I hope this message finds you well. I want to express my utmost gratitude for your excellent work and for the dedication and speed in the publication process of my article titled "Navigating Innovation: Qualitative Insights on Using Technology for Health Education in Acute Coronary Syndrome Patients." I am very satisfied with the peer review process, the support from the editorial office, and the quality of the journal. I hope we can maintain our scientific relationship in the long term.

img

Dr Maria Dolores Gomez Barriga